An undesired effect of preventive screening for cancer is often overlooked: it’s not only the tendency to diagnose more and more cancers that would be likely to grow slowly – and to increase overdiagnosis – but [more]
Oncology is understandably fascinated by ideas around precision treatment. As a medical oncologist who was there when the germs of this approach first appeared 50 years ago, I do of course share the excitement over [more]
May was awash with news stories about blood tests for prostate cancer. Reports that a new serum test called IsoPSA could predict prostate cancer more precisely than conventional PSA testing brought obvious interest. The new [more]
The risk of developing breast cancer varies widely from woman to woman in ways we are increasingly able to define. Marc Beishon asks: Is it time to move to population screening for risk, and tailor mammography schedules – [more]
Epidemiologists have long been warning of the rapid rise in cancer rates hitting low- and middle-income countries. But it takes a journalist to get across how those statistics are playing out in peoples lives. Jason [more]
As we learn more about what lies behind the differences in cancer outcomes across Europe, the question becomes: how do we end them? This article was first published in The Oncologist vol.18 no.12, and is [more]
If detected early, 80/90% of head and neck cancers can be cured. Yet lack of awareness means that two out of three cases are picked up late. The Make Sense campaign takes a message of [more]
Stigma breeds silence, which fuels the fear and ignorance that feeds the stigma. Breaking this vicious circle not only makes life easier for people with cancer, but can also change public attitudes towards prevention and [more]
Implement guidelines, adopt what works and reject what doesn’t, focus on cost-effectiveness–there are so many ways cancer care could be improved. Mary Gospodarowicz, believer, pragmatist and ‘raving optimist’, is determined to make it happen. Implement [more]